# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-020111
Filing Date
2021-04-22
Accepted
2021-04-22 16:15:22
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | hrtx-defa14a_20210617.htm | DEFA14A | 33787
2 | GRAPHIC | gu3o05rk1mxn000001.jpg | GRAPHIC | 794143
3 | GRAPHIC | gu3o05rk1mxn000002.jpg | GRAPHIC | 722949
| Complete submission text file | 0001564590-21-020111.txt |  | 2124386

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33221 | Film No.: 21844964
SIC: 2834 Pharmaceutical Preparations